Bio Protocol vs KAITO — how do they compare? Bio Protocol trades at Rp497.26 (market cap Rp1,12T, Rp283,83M 24h volume), while KAITO trades at Rp12,560 (market cap Rp3,04T, Rp485,59M 24h volume). The key difference: KAITO is far larger — about 2.7× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 241,4M / 1B KAITO (25%) for KAITO. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and KAITO for 11 Days on average.
| BIO | KAITO | |
|---|---|---|
Market Cap | Rp1,12T | Rp3,04T |
Volume (24h) | Rp283,83M | Rp485,59M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 241,4M / 1B KAITO (25%) |
Typical Hold Time | 16 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
KAITO is trading at Rp12,361 with a bullish technical signal, supported by strong moving averages and ADX readings indicating a robust trend. The token's market cap stands at Rp2.99 trillion, with a circulating supply of 241.4 million out of 1 million max supply, reflecting a 25% circulation rate. No major protocol updates or ecosystem news were reported recently, but the asset shows resilience above key support levels.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include low liquidity and regulatory uncertainty. Key opportunities lie in potential breakout above resistance, while major risks involve high volatility and limited on-chain activity. Investors should monitor exchange listings and community engagement for catalysts.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →KAITO is the native token and foundational component of the AI-powered InfoFi network. It serves several important functions: aligning incentives, empowering participants, and fostering the development of a fair and efficient AI-driven information finance ecosystem.
Read more on KAITO →